CSS
SWTX

Cubist Systematic Strategies’s SpringWorks Therapeutics SWTX Stock Holding History

Cubist Systematic Strategies’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,579
Closed -$356K – 3540
2025
Q2 		$356K Buy
+7,579
New +$337K ﹤0.01% 2394
2024
Q1 		– Sell
-6,941
Closed -$253K – 4252
2023
Q4 		$253K Buy
+6,941
New +$181K ﹤0.01% 2870
2023
Q2 		– Sell
-15,387
Closed -$396K – 4283
2023
Q1 		$396K Sell
15,387
-199,020
-93% -$5.82M ﹤0.01% 2813
2022
Q4 		$5.58M Buy
214,407
+43,506
+25% +$1.07M 0.03% 921
2022
Q3 		$4.88M Buy
170,901
+34,386
+25% +$986K 0.03% 1094
2022
Q2 		$3.36M Buy
+136,515
New +$4.99M 0.02% 1351
2022
Q1 		– Sell
-10,370
Closed -$643K – 3760
2021
Q4 		$643K Sell
10,370
-2,988
-22% -$198K 0.01% 2262
2021
Q3 		$847K Sell
13,358
-9,544
-42% -$735K 0.01% 1655
2021
Q2 		$1.89M Sell
22,902
-4,294
-16% -$326K 0.02% 1115
2021
Q1 		$2M Buy
27,196
+14,700
+118% +$1.15M 0.03% 1042
2020
Q4 		$906K Buy
12,496
+11,099
+794% +$714K 0.01% 1441
2020
Q3 		$67K Sell
1,397
-1,053
-43% -$44.8K ﹤0.01% 2338
2020
Q2 		$103K Buy
2,450
+1,772
+261% +$63.1K ﹤0.01% 2187
2020
Q1 		$18K Buy
+678
New +$22.1K ﹤0.01% 2069

Other funds holding SWTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Cubist Systematic Strategies's SWTX Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 7,579 shares — an estimated $356K sold.

Cubist Systematic Strategies first reported a position in SWTX in Q1 2020 and held it in 14 quarters. The position peaked at $5.58M in Q4 2022. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 7,579 SpringWorks Therapeutics shares in Q3 2025, an estimated $356K.
  • Cubist Systematic Strategies first reported a position in SpringWorks Therapeutics in Q1 2020 and held it in 14 quarters.
  • Cubist Systematic Strategies's SpringWorks Therapeutics position peaked at $5.58M in Q4 2022.
  • 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.